Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular’s CE Marked products, the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, will expand Stryker’s current portfolio of aneurysm treatment solutions.
Read the full article: Stryker Completes Acquisition of Cerus Endovascular //
Source: https://www.prnewswire.com/news-releases/stryker-completes-acquisition-of-cerus-endovascular-301812473.html